Keyphrases
EGFRvIII
100%
T Cell Persistence
100%
Metabolic Reprogramming
100%
Chimeric Antigen Receptor T Cells (CAR-T)
100%
Solid Tumors
40%
Tumor
26%
T Cells
20%
Heterogeneous Tumors
20%
Endogenous Immunity
13%
Host Immunity
13%
Tumor Killing
13%
T Cell Activation
13%
Metabolic Fitness
6%
Heterogeneous Solids
6%
Tumor Mouse Model
6%
T Cell Metabolism
6%
Cell Treatment
6%
Genetic Strategies
6%
Innovative Methods
6%
Effector T Cells
6%
T Cell Expansion
6%
Specific Intent
6%
Total Body Irradiation
6%
Immune System
6%
Metabolism
6%
Brain Tumor
6%
Cell Infusion
6%
Glioblastoma
6%
T Cell Proliferation
6%
Brain Tumor Model
6%
Pharmacological Strategies
6%
Cell Failure
6%
T Cell Differentiation
6%
Medicine and Dentistry
Chimeric Antigen Receptor T-Cell
100%
Neoplasm
46%
Solid Malignant Neoplasm
40%
Conditioning
40%
T Cell
20%
Cell Function
13%
Intracranial Tumor
13%
Infusion
6%
Tumor Model
6%
Glioblastoma
6%
Immunotherapy
6%
T Cell Proliferation
6%
Cell Expansion
6%
T Cell Differentiation
6%
In Vitro
6%
Whole Body Radiation
6%
Cell Metabolism
6%
Clinical Study
6%
Immunology and Microbiology
Chimeric Antigen Receptor T-Cell
100%
Conditioning
40%
T Cell
26%
Cell Function
13%
Cell Metabolism
6%
Preclinical Study
6%
Cell Expansion
6%
Immunotherapy
6%
Cell Differentiation
6%
Mouse Model
6%
T Cell Proliferation
6%